Orientations réglementaires
Post-Market Clinical Follow-Up Studies
Publié 20 mai 2021
Référence
IMDRF/MDCE WG/N65
Source
IMDRF
Statut
Final
Publié
20 mai 2021
Langues
EN
This document has been translated to Spanish by an external agency. The translation may be accessed from the agency's site by the link below.Please note that translations are for reference purposes only and responsibility for the accuracy of the translation belongs to the translating agency.Translation by IACRO into Spanish may be found here.
Source : IMDRF. Lire le document complet sur la source officielle.
Ce document s'ouvre sur le site de l'éditeur — sa licence ne permet pas de l'intégrer dans une visionneuse ici.
© International Medical Device Regulators Forum (IMDRF). Reproduced for non-commercial reference; see imdrf.org for terms.
Essential Principles and Content of Predetermined Change Control Plans
Publié 6 août 2026
Essential Principles and Content of Predetermined Change Control Plans
Publié 6 août 2026
IMDRF 29th MC Meeting Singapore March 2026 - Outcome Statement
Publié 7 avr. 2026
Terminologies for Categorized Adverse Event Reporting (AER): terms, terminology and codes
Publié 3 mars 2026